Skip to content
stoqly

Huntsman CORP

HUN NYSE Chemicals & Allied Products Financials FY2015–FY2024

Revenue Total sales reported in the income statement.
$5.7B
5.8% vs prior year
Operating margin Operating income as a share of revenue.
−2.3%
1.9 pts
Net income Profit after all expenses, interest and tax.
−$284M
Free cash flow Cash from operations minus capital spending.
$116M
46.8%
Return on capital After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
−2.4%
1.9 pts
Market cap Last close times the latest diluted share count, so it is approximate.
—
P/E Last close divided by diluted earnings per share over the last four quarters.
—
On −$1.93 EPS (TTM)

What Huntsman CORP does

No business description yet.

Legal name
Huntsman CORP
Fiscal year ends
December 31, 2025
Latest annual report
10-K · Feb 18, 2026
Accession · CIK
0001437749-26-004524
0001307954

Revenue and margins

Huntsman CORP had $5.7B of revenue in fiscal 2024, down 5.8% on the year before.

Revenue
Revenue
Margins, % of revenue
Gross Operating Net FCF
Margins, % of revenue
Gross Operating Net FCF

Net income and earnings per share

Loss periods are shown in red.

Net income
Net income
Diluted EPS
Diluted EPS

Returns on capital

After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

Return on capital, equity and assets (annual)
Return on capital Return on equity Return on assets

Cash flow

Free cash flow was $116M in fiscal 2024, 2.0% of revenue. Cash from operations minus capital spending.

Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations Capital spending
Cash from operations vs capital spending
Cash from operations Capital spending

Dividends, buybacks and share count

Huntsman CORP returned $146M to shareholders in fiscal 2024, 126% of free cash flow. The diluted share count rose 0.3%.

Dividends and buybacks
Dividends Buybacks
Dividends and buybacks
Dividends Buybacks
Diluted shares outstanding (annual)

Balance sheet

Cash, debt and the ratios that show how comfortably Huntsman CORP can carry it.

Cash vs debt (incl. leases)
Cash Debt
Fiscal year endFY20FY21FY22FY23FY24
Cash and short-term investments $1.0B$654M$540M$340M$429M
Debt incl. finance leases $1.6B$1.7B$1.7B$1.8B$2.0B
Net debt / EBITDA 0.5x1.1x3.2x5.7x10.1x
Debt / equity 0.4x0.5x0.5x0.6x0.7x
Current ratio 1.9x1.8x2.0x1.4x1.3x
Quick ratio 1.4x1.3x1.2x0.8x0.8x
Total assets $9.4B$8.2B$7.2B$7.1B$7.0B
Total liabilities $4.8B$4.4B$3.8B$4.0B$4.1B
Shareholders' equity $4.4B$3.6B$3.3B$3.0B$2.8B
Net debt (− = net cash) $509M$1.1B$1.1B$1.5B$1.6B

Insider trades

Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.

Bought, 12 months

$0.0M

0 insiders

Sold, 12 months

$0.0M

0 insiders

Of sales under plans

—

$0.0M

No open-market insider trades in the last 12 months.

Piotroski F-score

Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.

TestFY15FY16FY17FY18FY19FY20FY21FY22FY23FY24
Net income is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕ ✕
Cash from operations is positive ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Return on assets rose — ✓ ✕ ✓ ✓ ✕ ✕ ✕ ✕ ✕
Cash from operations exceeds net income ✓ ✓ ✓ ✓ ✕ ✕ ✓ ✓ ✓ ✓
Debt fell relative to assets — ✓ ✕ ✓ ✓ ✓ ✕ ✕ ✕ ✕
Current ratio rose — ✕ ✓ ✓ ✕ ✓ ✕ ✓ ✕ ✕
Share count didn't rise — ✕ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✕
Gross margin rose — ✓ ✕ ✕ ✕ ✓ ✕ ✕ ✕ ✕
Revenue rose relative to assets — ✕ ✓ ✕ ✕ ✓ ✓ ✕ ✓ ✕
F-score — / 36 / 96 / 97 / 95 / 97 / 95 / 95 / 94 / 92 / 9
Accruals ratio −8.3%−6.0%−9.6%−4.1%9.2%1.0%−5.2%−1.4%−6.3%−8.1%
Altman Z'' 1.812.672.442.542.853.633.643.202.311.87

10 years of figures

US$ millions unless stated. Hover a ratio's name for its definition.

Download CSV
Fiscal yearFY15FY16FY17FY18FY19FY20FY21FY22FY23FY24
Income statement
Revenue $7.5B $6.8B $7.6B $6.8B $5.4B $7.7B $8.0B $6.1B $6.0B $5.7B
Net interest income −$202M — — — — — — — — —
Gross profit $1.5B $1.7B $1.8B $1.4B $977M $1.6B $1.5B $906M $866M $751M
Research and development $137M $132M $145M $137M $121M $135M $125M $115M $121M $120M
Operating income $663M $729M $827M $469M $432M $731M $672M $84.0M −$25.0M −$131M
Pretax income $474M $531M $734M $391M $331M $1.2B $697M $99.0M −$39.0M −$192M
Income tax $109M $20.0M $45.0M −$38.0M $42.0M $191M $186M $64.0M $61.0M $26.0M
Net income $326M $636M $337M $562M $1.0B $1.0B $460M $101M −$189M −$284M
Net income to common — — $337M $562M $1.0B — — — — —
Diluted EPS $1.36 $2.61 $1.39 $2.44 $4.66 $4.72 $2.27 $0.57 −$1.10 −$1.65
Diluted shares 0.24B 0.24B 0.24B 0.23B 0.22B 0.22B 0.20B 0.18B 0.17B 0.17B
Cash flow
Cash from operations $1.1B $1.2B $1.2B $897M $253M $952M $914M $209M $263M $289M
Capital expenditure $318M $234M $251M $274M $237M $326M $272M $230M $184M $173M
Free cash flow $770M $985M $956M $623M $16.0M $626M $642M −$21.0M $79.0M $116M
Depreciation and amortization $318M $236M $255M $270M $267M $278M $281M $278M $289M $287M
Stock-based compensation $32.0M $36.0M $27.0M $29.0M $26.0M $30.0M $29.0M $28.0M $30.0M $31.0M
Acquisitions — $14.0M $366M $0.0M $650M $245M $0.0M $0.0M — —
Share buybacks — — $277M $208M $96.0M $200M $1.0B $349M $4.0M $0.0M
Dividends paid $120M $120M $156M $150M $144M $159M $171M $169M $174M $146M
Dividends and buybacks $120M $120M $433M $358M $240M $359M $1.2B $518M $178M $146M
Balance sheet
Cash and short-term investments $385M $470M $340M $525M $1.6B $1.0B $654M $540M $340M $429M
Total debt $4.2B $2.3B $2.4B $2.4B $2.1B $1.6B $1.7B $1.7B $1.8B $2.0B
Current assets $3.6B $6.0B $3.0B $3.8B $3.6B $3.9B $3.1B $2.3B $2.1B $2.1B
Current liabilities $1.8B $3.3B $1.6B $2.0B $2.0B $2.1B $1.7B $1.2B $1.6B $1.6B
Inventory $918M $1.1B $1.0B $914M $848M $1.0B $995M $867M $917M $818M
Property and equipment, net $3.0B $3.1B $2.4B $2.4B $2.5B $2.4B $2.4B $2.4B $2.5B $2.5B
Goodwill $121M $140M $275M $276M $533M $650M $641M $644M $633M $630M
Intangible assets $43.0M $56.0M $213M $197M $453M $469M $425M $387M $344M $308M
Total assets $9.2B $10.2B $8.0B $8.3B $8.7B $9.4B $8.2B $7.2B $7.1B $7.0B
Total liabilities $7.7B $6.9B $5.2B $5.5B $5.0B $4.8B $4.4B $3.8B $4.0B $4.1B
Shareholders' equity $1.3B $2.6B $2.5B $2.7B $3.5B $4.4B $3.6B $3.3B $3.0B $2.8B
Margins
Gross margin 20.2% 24.1% 23.2% 20.3% 18.0% 20.7% 19.3% 14.8% 14.3% 13.2%
Operating margin 8.8% 10.7% 10.9% 6.9% 8.0% 9.5% 8.4% 1.4% −0.4% −2.3%
EBITDA margin 13.0% 14.1% 14.2% 10.9% 12.9% 13.2% 11.9% 5.9% 4.4% 2.7%
Net margin 4.3% 9.3% 4.4% 8.3% 19.1% 13.6% 5.7% 1.7% −3.1% −5.0%
FCF margin 10.2% 14.4% 12.6% 9.2% 0.3% 8.2% 8.0% −0.3% 1.3% 2.0%
Net interest share of revenue −2.7% — — — — — — — — —
Returns
Return on capital 10.0% 15.6% 16.9% 10.3% 9.3% 12.7% 10.5% 1.2% −0.4% −2.4%
Return on capital employed 8.9% 10.4% 13.0% 7.4% 6.4% 10.0% 10.3% 1.4% −0.5% −2.4%
Return on equity 25.3% 32.6% 13.1% 21.6% 33.3% 26.5% 11.5% 2.9% −6.1% −9.9%
Return on assets 3.5% 6.5% 3.7% 6.9% 12.1% 11.5% 5.2% 1.3% −2.6% −4.0%
Return on tangible equity 29.0% 26.2% 16.6% 25.4% 40.8% 32.1% 18.0% 4.5% −9.5% −15.7%
Growth
Revenue growth — −9.0% 11.1% −10.6% −20.2% 41.5% 4.6% −23.8% −1.2% −5.8%
Net income growth — 95.1% −47.0% 66.8% 84.0% 1.1% −56.0% −78.0% −287.1% —
EPS growth — 91.9% −46.7% 75.5% 91.0% 1.3% −51.9% −74.9% −293.0% —
FCF growth — 27.9% −2.9% −34.8% −97.4% 3,812.5% 2.6% −103.3% — 46.8%
Share count change — 1.8% −0.9% −4.6% −3.8% −0.2% −8.3% −12.6% −3.0% 0.3%
Financial health
Net debt / EBITDA 3.9x 1.9x 1.9x 2.5x 0.8x 0.5x 1.1x 3.2x 5.7x 10.1x
Debt / equity 3.3x 0.9x 1.0x 0.9x 0.6x 0.4x 0.5x 0.5x 0.6x 0.7x
Current ratio 2.0x 1.8x 1.8x 1.9x 1.8x 1.9x 1.8x 2.0x 1.4x 1.3x
Quick ratio 1.5x 1.5x 1.2x 1.4x 1.4x 1.4x 1.3x 1.2x 0.8x 0.8x
Capital allocation
Capex / revenue 4.2% 3.4% 3.3% 4.0% 4.4% 4.3% 3.4% 3.8% 3.0% 3.0%
Stock comp / revenue 0.4% 0.5% 0.4% 0.4% 0.5% 0.4% 0.4% 0.5% 0.5% 0.5%
Payouts / FCF 15.6% 12.2% 45.3% 57.5% 1,500.0% 57.3% 183.2% — 225.3% 125.9%
Quality scores
Piotroski F-score — 6.0 6.0 7.0 5.0 7.0 5.0 5.0 4.0 2.0
Altman Z'' 1.8 2.7 2.4 2.5 2.8 3.6 3.6 3.2 2.3 1.9
Accruals ratio −8.3% −6.0% −9.6% −4.1% 9.2% 1.0% −5.2% −1.4% −6.3% −8.1%

Source: SEC EDGAR XBRL filings (CIK 0001307954). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.

↑ ↓ to move · ↵ to open